OOIR: Observatory of International Research

Papers

(The H4-Index of Microbial Biotechnology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
	155
Issue Information	101
Corrigendum	100
Controlled production of lipopolysaccharides increases immune activation in Salmonella treatments of cancer	92
Hyperproduction of PHA copolymers containing high fractions of 4‐hydroxybutyrate (4HB) by outer membrane‐defected Halomonas bluephagenesis grown in bioreactors	90
Modulation of yeast Erg1 expression and terbinafine susceptibility by iron bioavailability	76
Cultivating complexity: Advancements in establishing in vitro models for the mucus‐adhering gut microbiota	65
Proton motive force and antibiotic tolerance in bacteria	63
Patent landscape analysis—Contributing to the identification of technology trends and informing research and innovation funding policy	62
Combined Isotopic Tracer and Modelling Approach Reveals Differences in Nitrogen Metabolism in S. cerevisiae , S. uvarum	59
Can bioplastics always offer a truly sustainable alternative to fossil‐based plastics?	59
Rhodopsin‐based light‐harvesting system for sustainable synthetic biology	56
Characterisation and Harnessing of 5‐Hydroxymethylfurfural Metabolism in Pseudomonas umsongensis GO16 for the Production of 2,5‐Furandicarboxylic Acid	51
Unravelling the role of the group 6 soluble di‐iron monooxygenase (SDIMO) SmoABCD in alkane metabolism and chlorinated alkane degradation	49
Massive integration of large gene libraries in the chromosome of Escherichia coli	49
Bringing up to date the toolkit for the catabolism of aromatic compounds in fungi: The unexpected 1,2,3,5‐tetrahydroxybenzene central pathway	47
Harnessing the Ecological and Genomic Adaptability of the Bacterial Genus Massilia for Environmental and Industrial Applications	46
Journals Operating Predatory Practices Are Systematically Eroding the Science Ethos: A Gate and Code Strategy to Minimise Their Operating Space and Restore Research Best Practice	45
Use of non‐canonical amino acids in genetic code expansion‐based therapeutics: Effects on mouse gut microbiota	44
Biotechnological production optimization of argyrins – a potent immunomodulatory natural product class	42
Baogong decoction treats endometritis in mice by regulating uterine microbiota structure and metabolites	42
Co‐substrate composition is critical for enrichment of functional key species and for process efficiency during biogas production from cattle manure	41
Production of biofuels from C₁‐gases with Clostridium and related bacteria—Recent advances	40
LysJEP8: A promising novel endolysin for combating multidrug‐resistant Gram‐negative bacteria	40
Electrified bioreactors: the next power‐up for biometallurgical wastewater treatment	40

	40
Electrical current disrupts the electron transfer in defined consortia	39
Harnessing Gram‐negative bacteria for novel anti‐Gram‐negative antibiotics	39
Reduced Genetic Heterogeneity for Stable Bioproduction by Harnessing the Bias and Mechanism of Mutation	39
Hindrance to sustainable development: Global inequities, non‐progressive education and inadequate science‐policy dialogue	37
This is the Age of Microbial Technology: Crucial roles of learned societies and academies	37
In memoria of an outstanding microbiologist and friend, Pierre Cornelis	36
Dual Role of MtHAC‐1 in Regulating Cellulase and Xylanase Production in Myceliophthora thermophila	36
(Poly)phosphate biotechnology: Envisaged contributions to a sustainable P future	35
Development of a live biotherapeutic throat spray with lactobacilli targeting respiratory viral infections	34
Recent advances in producing food additive L‐malate: Chassis, substrate, pathway, fermentation regulation and application	34